These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25859672)

  • 1. The importance of precise documentation of vaccination by physicians and vaccine providers.
    Maurer W
    Curr Drug Saf; 2015; 10(1):27-30. PubMed ID: 25859672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating vaccine safety during the development and introduction of vaccines.
    Kochhar S
    Curr Drug Saf; 2015; 10(1):55-9. PubMed ID: 25859676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.
    Hibbs BF; Moro PL; Lewis P; Miller ER; Shimabukuro TT
    Vaccine; 2015 Jun; 33(28):3171-8. PubMed ID: 25980429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating vaccine safety to the media and general public.
    Oubari H; Tuttle R; Rath B; Bravo L
    Curr Drug Saf; 2015; 10(1):80-6. PubMed ID: 25859680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine safety monitoring systems in developing countries: an example of the Vietnam model.
    Ali M; Rath B; Thiem VD
    Curr Drug Saf; 2015; 10(1):60-7. PubMed ID: 25859677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Communicating vaccine safety in the context of immunization programs in low resource settings.
    Arwanire EM; Mbabazi W; Mugyenyi P
    Curr Drug Saf; 2015; 10(1):68-75. PubMed ID: 25859678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation.
    Bamford A; Manno EC; Mellado MJ; Spoulou V; Marques L; Scherpbier HJ; Niehues T; Oldakowska A; Rossi P; Palma P;
    Vaccine; 2016 Nov; 34(46):5587-5594. PubMed ID: 27727030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Communicating vaccine safety - the Vienna Vaccine Safety Initiative.
    Rath B
    Curr Drug Saf; 2015; 10(1):3-4. PubMed ID: 25859667
    [No Abstract]   [Full Text] [Related]  

  • 9. Historical aspects of immunization and vaccine safety communication.
    Helfert SM
    Curr Drug Saf; 2015; 10(1):5-8. PubMed ID: 25859668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of Vaccine Safety in Children with Chronic Conditions--Experience at the Scientific Centre for Children's Health in Moscow, Russia.
    Grechukha TA; Galitskaya MG; Namazova-Baranova LS
    Curr Drug Saf; 2015; 10(1):49-54. PubMed ID: 25859675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need to teach vaccine safety to basic scientists and public health officials.
    Khamesipour A
    Curr Drug Saf; 2015; 10(1):76-9. PubMed ID: 25859679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk communication of vaccines: challenges in the post-trust environment.
    Bouder F
    Curr Drug Saf; 2015; 10(1):9-15. PubMed ID: 25859669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the Immunisation Adverse Events Clinic at The Children's Hospital at Westmead.
    Wood NJ
    N S W Public Health Bull; 2010; 21(9-10):234-6. PubMed ID: 21211476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine information statements. Revolutionary but neglected educational advances in healthcare in the United States.
    Edlich RF; Martin ML; Foley ML; Gebhart JH; Winters KL; Britt LD; Long WB; Gubler KD
    J Long Term Eff Med Implants; 2005; 15(1):91-114. PubMed ID: 15715520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
    National Center for Immunization and Respiratory Diseases
    MMWR Recomm Rep; 2011 Jan; 60(2):1-64. PubMed ID: 21293327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in comparing the safety of different vaccination schedules.
    Jackson ML
    Vaccine; 2013 Apr; 31(17):2126-9. PubMed ID: 23470238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
    Varricchio F; Iskander J; Destefano F; Ball R; Pless R; Braun MM; Chen RT
    Pediatr Infect Dis J; 2004 Apr; 23(4):287-94. PubMed ID: 15071280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled language and information on vaccines: application to package inserts.
    Renahy J; Vuitton DA; Rath B; Thomas I; de Grivel V; Cardey S
    Curr Drug Saf; 2015; 10(1):41-8. PubMed ID: 25859674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.